DE MPJE study materials
DE MPJE study resources

DE MPJE: Delaware Pharmacy Law

DE MPJE · Work through your exam, one topic at a time.

All guide sections

Delaware Pharmacy Law

Delaware Pharmacy Law is the Board of Pharmacy domain: licensure, pharmacy permits, prescription validity, labeling, counseling, drug product selection, and records under 24 Del. C. ch. 25 and 24 DE Admin. Code 2500. The exam separates these state practice rules from the controlled-substance rules in the next section.

Licensure and permits

  • Pharmacists are licensed by the Delaware Board of Pharmacy; a pharmacy must hold a Delaware pharmacy permit. Interns and pharmacy technicians work under Board authorization and pharmacist supervision.
  • Continuing education is 30 contact hours per biennial renewal, including Board-required law and opioid content.
  • Licenses and permits must be current and displayed; changes in ownership, location, or pharmacist-in-charge require Board notification.

Prescription processing and labeling

  • A prescription must be issued for a legitimate medical purpose by a prescriber acting within scope and must contain patient, drug, strength, quantity, directions, date, and prescriber information.
  • Oral prescriptions are reduced to writing; controlled substances have extra limits covered in the CS section.
  • The label must show pharmacy name/address, Rx number, date, patient, prescriber, drug name/strength/quantity, directions, expiration or beyond-use date, and required cautions.
  • The pharmacist must offer counseling and document a refusal. Prescription records are kept at least two years and must be retrievable.

Drug product selection

Delaware allows substitution of an FDA-rated therapeutically equivalent generic unless the prescriber indicates brand medically necessary or the patient refuses. The dispensed product must be identified on the label, and the substitution documented.

Worked example

A prescription reads “Lipitor 20 mg #30 - DAW.” DAW means dispense as written; the pharmacist may not substitute atorvastatin even if the patient asks for generic. If the prescription instead reads “atorvastatin 20 mg” with no DAW, the pharmacist may select an AB-rated generic, label it accurately, counsel, and document. If the patient insists on brand, honor that request and record it; a patient request does not override a prescriber’s brand-medically-necessary instruction.

Traps

Do not assume a DEA registration substitutes for a Delaware pharmacy permit. Do not counsel by sticker alone or skip documenting refusal. Do not substitute when DAW/brand medically necessary appears, and do not change strength or dosage form without a new prescription. Do not apply federal record-retention assumptions blindly; follow Delaware Board rules.